4-methyl-4'-(3,5-bis(trifluoromethyl)-1H-pyrazol-1-yl)-1,2,3-thiadiazole-5-carboxanilide,
BTP2 cpd,
YM 58483,
YM-58483,
btp2,
223499-30-7,
YM-58483,
CRAC Channel Inhibitor, BTP2,
YM 58483,
YM-58483 (BTP2),
BTP-2,
CHEMBL262766,
N-[4-[3,5-bis(trifluoromethyl)pyrazol-1-yl]phenyl]-4-methylthiadiazole-5-carboxamide,
[N-{4-[3,5-bis(Trifluoromethyl)-1H-pyrazol-1-yl]phenyl}-4-methyl-1,2,3-thiadiazole-5-carboxamide],
N-(4-(3,5-bis(trifluoromethyl)-1H-pyrazol-1-yl)phenyl)-4-methyl-1,2,3-thiadiazole-5-carboxamide,
N-[4-[3,5-Bis(trifluoromethyl)-1H-pyrazol-1-yl]phenyl]-4-methyl-1,2,3-thiadiazole-5-carboxamide,
AC1L1DPT,
Maybridge3_006679,
ym-58483-btp2,
SCHEMBL676045,
GTPL2438,
CTK8E9854,
KS-00000UAS,
AOB3643,
DTXSID50274370,
HMS1449P13,
HMS3648I22,
ZINC591398,
BCP19298,
EX-A2467,
BDBM50204544,
CCG-55182,
MFCD00220976,
s8380,
AKOS024457886,
CS-6047,
IDI1_018066,
NCGC00344111-03,
AK685608,
AS-16763,
HY-100831,
RT-012103,
B7542,
A16346,
YM-58483, >=98% (HPLC),
SR-01000644222,
J-014660,
SR-01000644222-1,
SR-01000644222-3,
4-methyl-4'-[3,5-bis(trifluoromethyl)-1h-pyrazol-1-yl]-1,2,3-thiadiazole-5-carboxanilide,
1,2,3-thiadiazole-5-carboxamide,n-[4-[3,5-bis(trifluoromethyl)-1h-pyrazol-1-yl]phenyl]-4-methyl-,
4-methyl-4 inverted exclamation marka-[3,5-bis(trifluoromethyl)-1H-pyrazol-1-yl]-1,2,3-thiadiazole-5-carboxanilide,
BTP2 cpd,
D0JV2P,
CID2455,
ZINC00591398,
C476308,
4-methyl-4'-(3,5-bis(trifluoromethyl)-1h-pyrazol-1-yl)-1,2,3-thiadiazole-5-carboxanilide,